BPC-157 Peptide Therapy: What the Research Says

BPC-157 Peptide Therapy: What the Research Says

Patients ask about BPC-157 more than almost any other peptide at Albano Clinic. Given how much is circulating online — some of it accurate, much of it overstated — it’s worth laying out what the research actually shows, where the gaps are, and how we think about it clinically.

What BPC-157 Is

BPC stands for Body Protection Compound. BPC-157 is a synthetic peptide — a short chain of 15 amino acids — originally derived from a protective protein found in gastric juice. It has been studied extensively in animal models for its potential healing and anti-inflammatory properties, and it has attracted significant interest in sports medicine, regenerative medicine, and longevity practices.

It is not FDA-approved. It is available for research purposes and used off-label in some clinical settings. We are transparent about that distinction with every patient who asks about it.

What the Research Suggests

Most of the existing evidence comes from preclinical (animal) studies. Human clinical data is limited, and claims that outpace that evidence should be viewed skeptically. That said, the animal research is genuinely interesting and points toward several areas worth continued investigation.

Injury recovery. Animal studies suggest BPC-157 promotes angiogenesis (new blood vessel formation) and collagen synthesis — both critical to tendon, ligament, and muscle repair. Research has explored applications in tendon and ligament injuries, muscle tears, post-surgical healing, and tendon-to-bone reconnection.

Gastrointestinal health. BPC-157 was originally studied for its role in protecting the stomach lining. Findings suggest potential benefits for ulcer healing, inflammatory bowel conditions, and protection against NSAID-related GI damage.

Neuroprotection. Emerging preclinical evidence points toward possible roles in neural recovery following traumatic brain injury, stroke, and peripheral nerve injury.

Joint and bone health. Some studies indicate influence on inflammation and regeneration in cartilage and bone tissue — a natural area of interest given our focus on regenerative orthopedics.

Systemic anti-inflammatory effects. Unlike many compounds with localized action, BPC-157 appears to act through pathways that influence inflammation broadly — including nitric oxide modulation, growth factor stimulation, and gene expression regulation.

Side Effects and Safety

Anecdotal and experimental reports suggest BPC-157 is generally well tolerated. Reported side effects include mild headaches or dizziness (more common when combined with growth hormone peptides), injection site irritation, GI discomfort from low-quality oral preparations, and occasional mood or energy changes.

Long-term human safety data does not yet exist. This is not a reason to dismiss the compound — it is a reason to be honest about what we know and don’t know.

Who Should Avoid It

BPC-157 is not appropriate for everyone. We advise against use in patients with active cancer, cardiovascular disease, autoimmune disorders, liver or kidney disease, clotting issues, pregnancy or breastfeeding, or those under age 20.

Our Approach

Peptide therapy is one component of a broader regenerative and longevity toolkit. At Albano Clinic, we source only pharmaceutical-grade compounded peptides, discuss the evidence honestly, and recommend peptides only when they fit a patient’s specific goals and health profile.

If you’re curious whether BPC-157 or other peptides make sense for your situation, that’s a conversation worth having at your next consultation.